Augmenting the immunogenicity of carbohydrate tumor antigens
References (56)
- et al.
Prognostic significance of the CaMBrI antigen on breast carcinoma: relevance of the type of recognised glycoconjugate
Eur J Cancer
(1993) - et al.
Human monoclonal antibody to ganglioside GM2 for melanoma treatment
Lancet
(1989) - et al.
GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3
Vaccine
(1993) - et al.
Antibody response after immunization with gangliosides GD3, GD3 lactones, GD3 amide and GD3 gangliosidol in the mouse
- et al.
A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAcα2-6GalNAc, in mucin-type glycoproteins
J Biol Chem
(1988) - et al.
Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
The results of the serum treatment in thirteen hundred cases of epidemic meningitis
J Exp Med
(1913)- et al.
The soluble specific substance of pneumococcus
J Exp Med
(1923) - et al.
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
J Infect Dis
(1983) Blood group antigens as markers for normal differentiation and malignant change in human tissues
Am J Clin Pathol
(1987)
Approaches to augmenting the immunogenicity of melanoma gangliosides: From Whole melanoma cells to ganglioside-KLH conjugate vaccines
Immunol Rev
(1995)
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
J Exp Med
(1993)
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
J Exp Med
(1994)
A mutated CDK4 allele is recognized by autologous cytolytic T lymphocytes (CTL) in a human melanoma
Science
(1995)
Immunogenicity of melanoma-associated gangliosides in cancer patients
Int J Cancer
(1985)
Gangliosides GD2 specific monoclonal antibody 3F8: A phase I study in patients with neuroblastoma and malignant melanoma
J Clin Oncol
(1987)
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: A phase I trial in patients with malignant melanoma
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma
Cancer Res
(1992)
T and Tn. general carcinoma autoantigens
Science
(1984)
Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialvlated Tn
Cancer Res
(1992)
Cancer Immunol Immunother
(1995)
Sialosvl Tn: A novel mucin antigen associated with prognosis in colorectal cancer patients
Cancer
(1990)
Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate
Cancer Res
(1990)
Induction of a-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice
Cancer Res
(1991)
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications
J Clin Oncol
(1995)
Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: Purified GM2 is superior to whole cells
J Immunol
(1987)
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients
Comparison of approaches for augmenting the serological response to the Meth A antigen
Cited by (0)
Copyright © 1995 Published by Elsevier Ltd.